Calla Harrington, Clinical Supervisor at the Orange and Greenfield Opioid Treatment Program (OTP) will be a panelist during the opening session, "Broadening Perspectives to Narrow the Treatment Gap", which features a diverse group of experts. Calla will discuss how BHN's OTPs have responded to SAMHSA guidance, allowing for greater access to the life-saving medication methadone. She will also share insights into the reactions of staff and clients at BHN OTPs and how they have processed them. 

Dr. Ruth Potee, Medical Director for Substance Use Disorder services at BHN will join a panel discussion titled "Methadone in the Modern Era" on April 6th. She will be joined by Yngvild Olsen, Director of the Center for Substance Abuse Treatment (CSAT), and others advocating for change in the 51-year-old regulations on methadone administration in the United States. BHN's four opioid treatment clinics have served as statewide and national models of how to deliver methadone in a patient-centered and evidence-based model.